These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1997 related articles for article (PubMed ID: 35581606)

  • 1. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer.
    Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B
    J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TEAD4 as a Prognostic Marker Promotes Cell Migration and Invasion of Urinary Bladder Cancer via EMT.
    Huang Z; Yan Y; Tang P; Cai J; Cao X; Wang Z; Zhang F; Shen B
    Onco Targets Ther; 2021; 14():937-949. PubMed ID: 33603398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. POLR3G promotes EMT via PI3K/AKT signaling pathway in bladder cancer.
    Chen H; Ma L; Yang W; Li Y; Ji Z
    FASEB J; 2023 Dec; 37(12):e23260. PubMed ID: 37933949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin targets a YAP1-TEAD4 complex via AMPKα to regulate CCNE1/2 in bladder cancer cells.
    Wu Y; Zheng Q; Li Y; Wang G; Gao S; Zhang X; Yan X; Zhang X; Xie J; Wang Y; Sun X; Meng X; Yin B; Wang B
    J Exp Clin Cancer Res; 2019 Aug; 38(1):376. PubMed ID: 31455378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prognostic Hub Gene POLE2 Promotes BLCA Cell Growth via the PI3K/AKT Signaling Pathway.
    Jiang D; Zhang H; Yin B; He M; Lu X; He C
    Comb Chem High Throughput Screen; 2024; 27(13):1984-1998. PubMed ID: 38963027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wnt pathway-related three-mRNA clinical outcome signature in bladder urothelial carcinoma: computational biology and experimental analyses.
    Sun S; Wang Y; Wang J; Bi J
    J Transl Med; 2021 Sep; 19(1):409. PubMed ID: 34579753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway.
    Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W
    Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and validation of an immune signature associated with EMT and metabolic reprogramming for predicting prognosis and drug response in bladder cancer.
    Zhang Z; Yu Y; Li P; Wang M; Jiao W; Liang Y; Niu H
    Front Immunol; 2022; 13():954616. PubMed ID: 35958586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
    Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
    Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD146 Promotes EMT-Mediated Migration and Invasion of NSCLC via PI3K/Akt Signaling Pathway.
    Wei N; Wu X; Yu Y; Zhou H; Cui K; Zhao X; Zhang X
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):140. PubMed ID: 38682195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-β-induced transgelin promotes bladder cancer metastasis by regulating epithelial-mesenchymal transition and invadopodia formation.
    Chen Z; He S; Zhan Y; He A; Fang D; Gong Y; Li X; Zhou L
    EBioMedicine; 2019 Sep; 47():208-220. PubMed ID: 31420300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel defined inflammation-related long noncoding RNA signature contributes to predicting prognosis and distinction between the cold and hot tumors in bladder cancer.
    Xiong X; Chen C; Li X; Yang J; Zhang W; Wang X; Zhang H; Peng M; Li L; Luo P
    Front Oncol; 2023; 13():972558. PubMed ID: 37064115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of COL10A1 and its correlation with tumor-infiltrating immune cells in urothelial bladder cancer: A comprehensive study based on bioinformatics and clinical analysis validation.
    Wang X; Bai Y; Zhang F; Li D; Chen K; Wu R; Tang Y; Wei X; Han P
    Front Immunol; 2023; 14():955949. PubMed ID: 37006317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysine demethylase 2A promotes the progression of ovarian cancer by regulating the PI3K pathway and reversing epithelial‑mesenchymal transition.
    Lu DH; Yang J; Gao LK; Min J; Tang JM; Hu M; Li Y; Li ST; Chen J; Hong L
    Oncol Rep; 2019 Feb; 41(2):917-927. PubMed ID: 30483796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irisin/FNDC5 inhibits the epithelial-mesenchymal transition of epithelial ovarian cancer cells via the PI3K/Akt pathway.
    Zhu T; Zhang W; Zhang Y; Lu E; Liu H; Liu X; Yin S; Zhang P
    Arch Gynecol Obstet; 2022 Sep; 306(3):841-850. PubMed ID: 35156135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
    Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z
    Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TAGLN2 Promotes the Proliferation, Migration, Invasion, and EMT of Clear Cell Renal Cell Carcinoma Through the PI3K/Akt Signaling Pathway.
    He Y; Zhang B; Han D; Du Y; Zhang X; Wang H; Yue Z; Shang P
    Biochem Genet; 2023 Aug; 61(4):1265-1281. PubMed ID: 36547768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compound Kushen injection inhibits EMT of gastric cancer cells via the PI3K/AKT pathway.
    Li L; Wang K; Liu Z; Lü Y; Wang C; Yi X; Guo J
    World J Surg Oncol; 2022 May; 20(1):161. PubMed ID: 35590327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rotenone restrains colon cancer cell viability, motility and epithelial‑mesenchymal transition and tumorigenesis in nude mice via the PI3K/AKT pathway.
    Xiao W; Liu Y; Dai M; Li Y; Peng R; Yu S; Liu H
    Int J Mol Med; 2020 Aug; 46(2):700-708. PubMed ID: 32626924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 100.